(Q57131881)

1

0 references

C Forino

3

0 references

D De Martiis

4

0 references

C Offer

5

0 references

A Lanfranchi

6

0 references

S Giliani

7

0 references

L Imberti

8

0 references

S Pasic

9

0 references

A G Ugazio

10

0 references

F Porta

11

0 references

L D Notarangelo

Bone Marrow Transplantation

12

0 references

language of work or name

English

0 references

publication date

23 May 2005

0 references

published in

0 references

volume

36

0 references

issue

2

0 references

page(s)

107-114

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705017

0 references

cites work

Reviewing Omenn syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

Genetic immunodeficiencies: Cutaneous manifestations and recent progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

Partial V(D)J recombination activity leads to Omenn syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

Impaired thymic output and restricted T-cell repertoire in two infants with immunodeficiency and early-onset generalized dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

AIRE deficiency in thymus of 2 patients with Omenn syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

Familial Reticuloendotheliosis with Eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

7 January 2021

Highly restricted human T cell repertoire in peripheral blood and tissue-infiltrating lymphocytes in Omenn's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

7 January 2021

In vitro cell death of activated lymphocytes in Omenn's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

7 January 2021

Treatment of Omenn syndrome by bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

7 January 2021

In vitro Detection of Immunosuppressive Activity of Anti-lymphocyte Sera

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

7 January 2021

Immunological reconstitution of sex-linked lymphopenic immunological deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

7 January 2021

Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

7 January 2021

Non-myeloablative stem cell transplantation for severe combined immunodeficiency--Omenn syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

7 January 2021

Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

7 January 2021

Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705017

7 January 2021